Skip to main content

Table 4 ART related adverse events experienced by patients and proportions that had adverse events in patients that were LTFU versus those still in care, Tshepang Pharmacovigilance cohort, 2004-2012

From: Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004–2012: a cohort study

Adverse event Total LTFU In Care
  N % n (%) n %
Peripheral Neuropathy 165 52.2 39 28.1 126 21.2
Lipodystrophy 121 38.3 11 7.2 110 24.1
Hyperlactateaemia 83 26.3 13 9.4 70 15.4
*Others 19 6.0 6 4.3 13 2.9
  1. *Others include anaemia, various dermatological adverse events, Central nervous system adverse events, diarrhoea and vomiting, lipid abnormalities and hepatititis